Search Results 731-740 of 16062 for pharmacogenetics
The secondary aim of this study is to assess the relationship between this digital phenotype and markers of disease severity outcome, including MELD score and ...
Seifar F, Fox EJ, Shantaraman A, Liu Y, Dammer EB, Modeste E, Duong DM, Yin L, Trautwig AN, Guo Q, Xu K, Ping L, Reddy JS, Allen M, Quicksall Z, Heath L, ...
Focal dermal hypoplasia (Goltz-Gorlin syndrome). Hemangioma. Hypohidrotic ectodermal dysplasia. Hypomelanosis of Ito. Ichthyosis vulgaris. Keratosis ...
Gebhart, M.D., M.S., is a fellowship trained Urogynecologist, specializing in Urogynecology and Reconstructive Pelvic Surgery. He is board certified in both ...
These themes are organized to follow a classic cell signaling cascade from the plasma membrane to nuclear events: Cellular networks. About 37% of our ...
The purpose of this study is to examine the role of an Early Recovery After Surgery (ERAS) protocol designed for posterior cervical spinal fusion. Participation ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Ixazomib citrate may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, such as lenalidomide ...
Contact Dr. Kullo about education opportunities for postdoctoral studies in his Atherosclerosis and Lipid Genomics Lab at Mayo Clinic.
The Center for Cell Signaling in Gastroenterology at Mayo Clinic includes faculty members with expertise in biochemistry, molecular biology, endocrinology, ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your GivingTuesday gift can go 2X as far.